Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.

Adrian H HealdAnthony A FryerSimon G AndersonMark LivingstonMark LuntMark DaviesGabriela Y C MorenoRoger GadsbyRobert J YoungMike Stedman

Published in: Diabetes, obesity & metabolism (2018)

Greater use of newer agents was associated with improvement in glycaemic outcomes but was not sufficient to compensate for the prevailing decline. This may reflect wide variability in the prescribing of newer agents. We found that SGLT inhibitors may be superior to other oral agents in relation to HbA1c outcome. Serious consideration should be given to their use.

Keyphrases

general practice
type diabetes
primary care
emergency department
metabolic syndrome
insulin resistance
adverse drug